Register

COURSE DESCRIPTION:  

Recent advances in the field of cancer research led to diagnostic and therapeutic innovations, such as targeted therapies as a standard therapeutic approach for personalized cancer medicine. Over sixty percent of cancer patients receive radiation therapy as part of their cancer treatment. Doctors use radiation therapy to treat nearly every type of cancer. Please join us in this lecture for an overview about the role of radiation therapy as part of multimodality cancer care. Novel technologies used in radiotherapy delivery will be discussed.

TARGET AUDIENCE:

Internal Medicine Physicians, Physician Assistants, Residents, Advanced Practice Registered Nurses, Podiatrists, Pharmacists and all other interested healthcare providers. 

LEARNING OBJECTIVES:

• Explain the role of radiation therapy as part of multimodality cancer care. 
• Identify novel technologies used in radiotherapy delivery.

FACULTY AND DISCLOSURES:

Youssef Zeidan, M.D., Ph.D.
Radiation Oncologist
Lynn Cancer Institute
Affiliate Associate Professor
Florida International University

Youssef Zeidan, M.D., Ph.D., faculty for this educational activity, has no relevant financial relationships with ineligible companies* to disclose, and has indicated that the presentation or discussion will not include off-label or unapproved product usage.
 

John Rubin, M.D., director for this educational event, owns stock in AstraZeneca and Bristol Myers Squibb. He has indicated that the presentation or discussion will not include off-label or unapproved product usage. All of the relevant financial relationships listed for this individual have been mitigated.  

Kenneth Rosenthal, M.D., FACG, moderator for this educational event, indicated that he is on the Speaker’s Bureau for AbbVie, Inc. All of the relevant financial relationships listed for this individual has been mitigated. 

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.
 

Disclosure Policy and Disclaimer

ACCREDITATION STATEMENTS AND CREDITS

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.   

This activity has been approved for 1 credit hour, CE Broker Course #20-855339, by the Florida Boards of Medicine, Podiatry, Osteopathic Medicine and Physician Assistants.  

This activity has also been approved for 1 credit for Nurse Practitioners, Nurses, Pharmacists and Pharmacy Techs, Athletic Trainers. Baptist Health South Florida CE Broker Provider #50-182.